Literature DB >> 31064656

Chronic pain after reoperation of an inguinal hernia with Lichtenstein or laparoscopic repair following a primary Lichtenstein repair: A nationwide questionnaire study.

Stina Öberg1, Kristoffer Andresen2, Jason J Baker2, Eva Angenete3, Jacob Rosenberg2.   

Abstract

BACKGROUND: The aim was to assess chronic pain after two Lichtenstein repairs for inguinal hernias (Lichtenstein-Lichtenstein) compared with Lichtenstein followed by a laparoscopic reoperation (Lichtenstein-Laparoscopy).
METHODS: In this cohort study, adults having an inguinal hernia reoperation were identified in a nationwide database. Lichtenstein-Lichtenstein was matched 1:3 with Lichtenstein-Laparoscopy and sent validated pain questionnaires. The primary outcome was difference in proportion of patients with chronic pain-related functional impairment. Secondary outcomes were differences in chronic pain prevalence and severity.
RESULTS: In total, 196 patients having Lichtenstein-Lichtenstein and 777 patients having Lichtenstein-Laparoscopy were included. There was no difference in the primary outcome, 26% with pain in Lichtenstein-Lichtenstein versus 19% in Lichtenstein-Laparoscopy (p = 0.051). However, a few of the secondary outcomes favored Lichtenstein-Laparoscopy.
CONCLUSIONS: A high proportion of patients in both groups had pain several years after the second repair. None of the analyses favored Lichtenstein-Lichtenstein, but a few of the secondary outcomes favored Lichtenstein-Laparoscopy.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31064656     DOI: 10.1016/j.amjsurg.2019.04.015

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  1 in total

1.  Technical details and findings during a second Lichtenstein repair or a second laparoscopic repair in the same groin: a study based on medical records.

Authors:  Stina Öberg; Majken Lyhne Jessen; Kristoffer Andresen; Jacob Rosenberg
Journal:  Hernia       Date:  2019-11-30       Impact factor: 4.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.